PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 80 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $28,143,000 | 7.62% |
| Frazier Life Sciences Management, L.P. | 5,827,415 | $79,311,000 | 6.76% |
| Abingworth LLP | 1,435,106 | $19,503,000 | 5.53% |
| Penn Mutual Asset Management, LLC | 86,940 | $1,183,000 | 1.37% |
| MPM BioImpact LLC | 193,326 | $2,631,000 | 0.71% |
| Avidity Partners Management LP | 1,946,000 | $26,485,000 | 0.55% |
| StepStone Group LP | 422,085 | $5,745,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 235,210 | $3,201,000 | 0.32% |
| Summit Rock Advisors, LP | 34,100 | $464,000 | 0.28% |
| Parkman Healthcare Partners LLC | 65,553 | $892,000 | 0.26% |